The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.18
Bid: 15.06
Ask: 15.14
Change: 0.24 (1.61%)
Spread: 0.08 (0.531%)
Open: 15.50
High: 15.50
Low: 14.66
Prev. Close: 14.94
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EnQuest PLC proposes to offer senior notes

26 Mar 2014 07:02

RNS Number : 1902D
EnQuest PLC
26 March 2014
 



 

 

 

EnQuest PLC (ENQ)

 

EnQuest PLC proposes to offer senior notes

 

London, March 2014 - EnQuest PLC ("EnQuest" or the "Company") today announces that it intends to offer $500 million in aggregate principal amount of senior unsecured notes due 2022 (the "Notes"). The Notes, the net proceeds of which will be used for general corporate purposes, will be senior obligations of the Company and will rank pari passu with all present and future senior unsecured indebtedness of the Company. The guarantees of the Notes by certain subsidiaries of the Company will be subordinated to the obligations of the Guarantors under the Company's senior secured revolving credit facility.

 

* * *

 

This announcement does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other security and shall not constitute an offer, solicitation or sale in the United States or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any jurisdiction.

The Notes and the related guarantees have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

 

This announcement may include projections and other "forward-looking" statements within the meaning of applicable securities laws. Any such projections or statements reflect the current views of the Company about future events and financial performance. The use of any of the words "expect," "anticipate," "continue," "will," "project," "should," "believe," "plans," "intends" and similar expressions are intended to identify forward-looking information or statements. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that such statements and information will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

 

The forward-looking statements and information contained in this announcement are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

 

Within the United Kingdom, this announcement is directed only at persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 ("relevant persons"). The investment or investment activity to which this announcement relates is only available to and will only be engaged in with relevant persons and person who receive this announcement who are not relevant persons should not rely or act upon it.

 

This press release shall not be considered an "offer of securities to the public" for purposes of the Luxembourg law on prospectus for public offering dated 10 July 2005 or give rise to or require the publication of a prospectus in any EU member state which has implemented Directive 2003/71/EC (together with any applicable implementing measures, including Directive 2010/73/EC, in any member state).

 

Ends

 

 

 

For further information please contact:

 

EnQuest PLC

Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive)

Jonathan Swinney (Chief Financial Officer)

Michael Waring (Head of Communications & Investor Relations)

 

Tulchan Communications

Tel: +44 (0)20 7353 4200

Martin Robinson

David Allchurch

Martin Pengelley

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSESEEIFLSEFD
Date   Source Headline
23rd Feb 202111:41 amRNSHolding(s) in Company
22nd Feb 20219:00 amRNSHolding(s) in Company
19th Feb 20213:21 pmRNSHolding(s) in Company
18th Feb 20213:09 pmRNSAdmission to trading
18th Feb 20219:00 amRNSHolding(s) in Company
9th Feb 202110:00 amRNSHolding(s) in Company
5th Feb 20212:49 pmRNSHolding(s) in Company
4th Feb 20215:52 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSOperations update
4th Feb 20217:00 amRNSAgreement to acquire UKNS asset
3rd Feb 20212:45 pmRNSHolding(s) in Company
3rd Feb 20218:30 amRNSDirectorate Change
29th Jan 20219:12 amRNSBond PIK Announcement
21st Jan 20217:00 amRNSAcquisition
11th Jan 20212:12 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:00 amRNSOperations update
23rd Oct 20208:56 amRNSBoard Appointment
15th Oct 20209:19 amRNSMaturity date extension: High Yield & Retail Notes
17th Sep 202010:07 amRNSDirector/PDMR Shareholding
14th Sep 20209:22 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSEnQuest PLC Half Year Results 2020
20th Aug 202011:14 amRNSAdmission to Trading
31st Jul 20207:00 amRNSEnQuest signs sale and purchase agreement
30th Jul 202010:37 amRNSBond PIK Announcement
29th Jun 20202:11 pmRNSPayments to governments
9th Jun 202012:20 pmRNSDirector/PDMR Shareholding
21st May 20204:20 pmRNSAGM Statement
21st May 20207:00 amRNSOperations update
4th May 202010:22 amRNSDirector/PDMR Shareholding
1st May 20204:26 pmRNSHolding(s) in Company
27th Apr 202010:52 amRNSDirector/PDMR Shareholding
24th Apr 20209:23 amRNSDirector/PDMR Shareholding
23rd Apr 20204:06 pmRNSNotice of AGM and Report & Accounts
21st Apr 202010:31 amRNSDirector/PDMR Shareholding
20th Apr 20203:25 pmRNSDirector/PDMR Shareholding
20th Apr 20202:55 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSEnQuest 2019 Full Year Results
8th Apr 20208:00 amRNSNotification of full year results announcement
2nd Apr 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20202:57 pmRNSFull year results update
19th Mar 20204:16 pmRNSDirectorate Change
19th Mar 20207:00 amRNSOperations update
20th Feb 20203:58 pmRNSAdmission to Trading
4th Feb 20207:00 amRNSOperations update
31st Jan 202011:59 amRNSBond PIK Announcement
6th Jan 202012:14 pmRNSTotal Voting Rights
9th Dec 201910:39 amRNSDirector/PDMR Shareholding
4th Dec 201912:48 pmRNSBlock listing Interim Review
4th Dec 20197:00 amRNSEnQuest awarded Block PM409 PSC offshore Malaysia

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.